Catherine Madigan

Insider Reports History

Location
Waltham, MA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Madigan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Medical Officer Stock Options (Right to buy) 110,000 $2,128,500 $19.35 02 Feb 2023 Direct

Insider Reports Filed by Catherine Madigan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 +$3,140,500 4 Chief Medical Officer 03 Feb 2023, 16:01
SNDX Syndax Pharmaceuticals Inc 01 Mar 2022 1 +$2,890,800 4 Chief Medical Officer 03 Mar 2022, 15:24
SNDX Syndax Pharmaceuticals Inc 01 Mar 2022 0 $0 3 Chief Medical Officer 03 Mar 2022, 15:18